Shannon Weiman
Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.
Honoring Beth Levine: A Tribute from the Autophagy eSymposia
Last month the Autophagy community assembled virtually to share their latest discoveries and insights, with enthusiasm and inspiration. But missing from their ranks was a key leader, mentor and friend-- Beth Levine-- who tragically...
Dr. Emily Smith on “Optimizing Nutrition for Maternal, Newborn and Child Health”
On Wednesday, October 21, 2020, an international consortium of researchers from over 55 countries worldwide convened in virtual format for the "Optimizing Nutrition for Maternal, Newborn and Child Health" eSymposia, held in conjunction with...
Editor Insights: Cell Press’ Dr. Narasimhan on “Optimizing Nutrition for Maternal, Newborn and Child...
Keystone Symposia meetings, whether in-person or virtual, are important venues to connect editors with scientists to facilitate publication for both parties. At the upcoming "Optimizing Nutrition for Maternal, Newborn and Child Health"eSymposia, Dr. Sri Devi...
Editor Reflections: Claudia Willmes of Cell Press on RNA Editing eSymposia
Keystone Symposia meetings, whether in-person or virtual, are important venues to connect editors with scientists to facilitate publication for both parties. Here we connect with Dr. Claudia Willmes, Editor for Trends in Molecular Medicine...
[Podcast] Discussing Cancer Immunology & the Foreign Scholars Visa Ban with Dr. Merad
In their latest podcast, The Scientist LabTalk highlights Dr. Miriam Merad, a speaker at the upcoming “Myeloid Cells & Innate Immunity in Solid Tumors” eSymposia. Dr. Merad is a leader in immune-oncology research, as...